Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in CashFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Growth Metrics
Income Statement
Others
Ratios

Goldenwell Biotech (GWLL) Change in Account Payables (2021 - 2022)

Goldenwell Biotech (GWLL) has disclosed Change in Account Payables for 2 consecutive years, with -$111488.0 as the latest value for Q3 2022.

  • For the quarter ending Q3 2022, Change in Account Payables changed N/A year-over-year to -$111488.0, compared with a TTM value of -$111488.0 through Mar 2024, changed 0.0%, and an annual FY2022 reading of -$111488.0, down 200.0% over the prior year.
  • Change in Account Payables was -$111488.0 for Q3 2022 at Goldenwell Biotech, roughly flat from -$111488.0 in the prior quarter.
  • Across five years, Change in Account Payables topped out at $8363.0 in Q4 2021 and bottomed at -$111488.0 in Q1 2022.